Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Co-Developing Strategies for Patient Engagement in Decentralized Rheumatic Heart Disease Care: Lessons from Northern Uganda.

Global heart·2026
Same journal

A Thematic Analysis of Key Informant Interviews on the Implementation Experience of the HEARTS Hypertension Program in Nigeria.

Global heart·2026
Same journal

<i>Streptococcus Pyogenes</i> and Acute Rheumatic Fever: How Strong are the Links in the Chain?

Global heart·2026
Same journal

Joint Associations of Cumulative C-Reactive Protein-Triglyceride-Glucose Index and Depression with Cardiovascular Outcomes in Middle-Aged and Older Adults: A National Prospective Cohort Study.

Global heart·2026
Same journal

The Creation of the Cardiac Society of Timor-Leste: A Major Step Forward in Timorese Cardiac Health.

Global heart·2026
Same journal

Factors Influencing the Uptake of Digital Health Interventions for Cardiovascular Disease Prevention Among Healthcare Providers: A Systematic Review.

Global heart·2026
See all related articles

Related Experiment Video

Updated: Jun 16, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Mortality Outcome Post-MI after PCI and CABG Interventions.

Mina Muayad Alwan Al-Naqdi1, Mohammed Lateef Mohammed Alkhammasi2, Bassam Muayad Alwan Al-Naqdi3

  • 1Al-Mustansiriyah Primary Healthcare Center, Baghdad, Iraq.

Global Heart
|June 15, 2026
PubMed
Summary
This summary is machine-generated.

Three-year mortality after myocardial infarction (MI) did not differ significantly between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). Non-cardiac causes were the leading cause of death in both groups.

Keywords:
CABGCox regressionMIPCImortality ratesurvival analysis

Related Experiment Videos

Last Updated: Jun 16, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Myocardial infarction (MI) remains a leading global cause of death.
  • Effective revascularization strategies are crucial for post-MI patient outcomes.

Purpose of the Study:

  • To compare three-year mortality outcomes between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in post-MI patients.
  • To identify causes of death in patients undergoing PCI versus CABG.

Main Methods:

  • Retrospective cohort study of 6,786 post-MI patients (3,542 PCI, 3,244 CABG) from 2020-2024.
  • Kaplan-Meier analysis for unadjusted survival and Cox regression for adjusted three-year all-cause mortality.
  • Adjustment for baseline demographic and clinical covariates to mitigate confounding.

Main Results:

  • Crude mortality was 7.99% for PCI and 11.19% for CABG.
  • Adjusted three-year all-cause mortality hazard was not significantly different between PCI and CABG (aHR = 1.12, p = 0.280).
  • Independent predictors of mortality included age, diabetes mellitus, and renal complications; non-cardiovascular causes predominated deaths (50-56%).

Conclusions:

  • Adjusted three-year mortality is similar between PCI and CABG post-MI.
  • Non-cardiac causes represent the majority of deaths, highlighting broader health factors.
  • PCI and CABG remain vital, with patient selection guided by heart-team assessment.